- You are here: Home
- Protocol
- Generation Protocol of Human iPSCs from Peripheral Blood Using Lentiviral Vectors
About Us
-
Cell Services
- Cell Line Authentication
- Cell Surface Marker Validation Service
-
Cell Line Testing and Assays
- Toxicology Assay
- Drug-Resistant Cell Models
- Cell Viability Assays
- Cell Proliferation Assays
- Cell Migration Assays
- Soft Agar Colony Formation Assay Service
- SRB Assay
- Cell Apoptosis Assays
- Cell Cycle Assays
- Cell Angiogenesis Assays
- DNA/RNA Extraction
- Custom Cell & Tissue Lysate Service
- Cellular Phosphorylation Assays
- Stability Testing
- Sterility Testing
- Endotoxin Detection and Removal
- Phagocytosis Assays
- Cell-Based Screening and Profiling Services
- 3D-Based Services
- Custom Cell Services
- Cell-based LNP Evaluation
-
Stem Cell Research
- iPSC Generation
- iPSC Characterization
-
iPSC Differentiation
- Neural Stem Cells Differentiation Service from iPSC
- Astrocyte Differentiation Service from iPSC
- Retinal Pigment Epithelium (RPE) Differentiation Service from iPSC
- Cardiomyocyte Differentiation Service from iPSC
- T Cell, NK Cell Differentiation Service from iPSC
- Hepatocyte Differentiation Service from iPSC
- Beta Cell Differentiation Service from iPSC
- Brain Organoid Differentiation Service from iPSC
- Cardiac Organoid Differentiation Service from iPSC
- Kidney Organoid Differentiation Service from iPSC
- GABAnergic Neuron Differentiation Service from iPSC
- Undifferentiated iPSC Detection
- iPSC Gene Editing
- iPSC Expanding Service
- MSC Services
- Stem Cell Assay Development and Screening
- Cell Immortalization
-
ISH/FISH Services
- In Situ Hybridization (ISH) & RNAscope Service
- Fluorescent In Situ Hybridization
- FISH Probe Design, Synthesis and Testing Service
-
FISH Applications
- Multicolor FISH (M-FISH) Analysis
- Chromosome Analysis of ES and iPS Cells
- RNA FISH in Plant Service
- Mouse Model and PDX Analysis (FISH)
- Cell Transplantation Analysis (FISH)
- In Situ Detection of CAR-T Cells & Oncolytic Viruses
- CAR-T/CAR-NK Target Assessment Service (ISH)
- ImmunoFISH Analysis (FISH+IHC)
- Splice Variant Analysis (FISH)
- Telomere Length Analysis (Q-FISH)
- Telomere Length Analysis (qPCR assay)
- FISH Analysis of Microorganisms
- Neoplasms FISH Analysis
- CARD-FISH for Environmental Microorganisms (FISH)
- FISH Quality Control Services
- QuantiGene Plex Assay
- Circulating Tumor Cell (CTC) FISH
- mtRNA Analysis (FISH)
- In Situ Detection of Chemokines/Cytokines
- In Situ Detection of Virus
- Transgene Mapping (FISH)
- Transgene Mapping (Locus Amplification & Sequencing)
- Stable Cell Line Genetic Stability Testing
- Genetic Stability Testing (Locus Amplification & Sequencing + ddPCR)
- Clonality Analysis Service (FISH)
- Karyotyping (G-banded) Service
- Animal Chromosome Analysis (G-banded) Service
- AAV Biodistribution Analysis (RNA ISH)
- Molecular Karyotyping (aCGH)
- Droplet Digital PCR (ddPCR) Service
- Digital ISH Image Quantification and Statistical Analysis
- SCE (Sister Chromatid Exchange) Analysis
- Biosample Services
- Histology Services
- Exosome Research Services
- In Vitro DMPK Services
-
In Vivo DMPK Services
- Pharmacokinetic and Toxicokinetic
- PK/PD Biomarker Analysis
- Bioavailability and Bioequivalence
- Bioanalytical Package
- Metabolite Profiling and Identification
- In Vivo Toxicity Study
- Mass Balance, Excretion and Expired Air Collection
- Administration Routes and Biofluid Sampling
- Quantitative Tissue Distribution
- Target Tissue Exposure
- In Vivo Blood-Brain-Barrier Assay
- Drug Toxicity Services
Generation Protocol of Human iPSCs from Peripheral Blood Using Lentiviral Vectors
GUIDELINE
Through the ectopic expression of four transcription factors, Oct4, Klf4, Sox2 and cMyc, human somatic cells can be converted to a pluripotent state, generating so-called induced pluripotent stem cells (iPSCs). Patient-specific iPSCs lack the ethical concerns surrounding embryonic stem cells (ESCs) and would bypass possible immune rejection. Thus, iPSCs have attracted considerable attention for disease modeling studies, the screening of pharmacological compounds, and regenerative therapies.
METHODS
Expansion of peripheral blood mononuclear cells (PBMCs)
- To start the protocol using frozen PBMCs, thaw 1 vial of cells into 10 ml of QBSF medium and centrifuge at 300×g for 10 min. Resuspend the cells in 2 ml of expansion medium (EM) and transfer them to one well of a 12-well plate. Incubate the cells in a 37°C, 5% CO2 incubator.
- Transfer the cells to a sterile 15 ml conical tube and wash the well once with 1 ml of QBSF-60 stem cell medium to collect adherent cells. Centrifuge the cells at 300×g for 10 min.
- Resuspend the cells in 2 ml of EM and transfer to one well of a 12-well plate. Incubate the cells in a 37°C, 5% CO2 incubator.
Transduction of PBMCs with lentivirus
- Resuspend the cells in 1 ml of fresh EM containing 5 μg/ml of polybrene and lentivirus and transfer to one well of a 12-well plate. Spin the plate at 2250 rpm at 25°C for 90 min.
- After spin, add 1 ml of fresh EM containing 5 μg/ml of polybrene for a total of 2 ml of medium and incubate the plate in a 37°C, 5% CO2 incubator.
- The next day, resuspend the cells in 2 ml of EM and transfer to 1 well of a 12-well plate. Incubate the cells in a 37°C, 5% CO2 incubator.
Plating transduced cells onto MEFs
- Coat the wells of a 6-well plate with 0.1% gelatin and plate-inactivated mouse embryonic fibroblasts (MEFs) at 2×105 cells/well in MEF medium. Prepare 3 wells per infection.
- Resuspend the cells in 3 ml of MEF medium containing 10 ng/ml bFGF, ascorbic acid, and growth factors at the same concentrations as used in the EM medium.
- Plate 1 ml of cells per well of a 6-well plate containing MEFs. Add 1.5 ml of MEF media with bFGF, ascorbic acid, and growth factors for a total of 2.5 ml of media/well.
- Spin the plate at 500 rpm at 25°C for 30 min. Incubate the plate in a 37°C, 5% CO2 incubator.
- Feed cells every other day with 2.5 ml of MEF media containing 10 ng/ml bFGF and 50 μg/ml ascorbic acid (no growth factors). Aspirate and discard floating cells with each feed.
- Once small colonies appear, feed cells daily with 2 ml of human embryonic stem cell (hESC) medium.
Picking and expansion of iPSC clones
- Pick each colony in individual wells of a 12-well plate pre-seeded with inactivated MEFs containing 1 ml/well of hESC medium plus 10 μM of ROCK inhibitor.
Creative Bioarray Relevant Recommendations
- Creative Bioarray is dedicated to providing several viable and cost-effective methods for pluripotent stem cell (iPSC) generation. We employ advanced iPSC reprogramming factor delivery by episomal vectors, viral vectors, as well as other iPSC reprogramming methods (mRNA, protein, and chemical reprogramming) to help you obtain the desired iPSC.
NOTES
- When less than 5×105 cells are transduced, cells may be plated onto one or two wells of a 6-well plate containing MEFs.
- We have experienced some variability in the time necessary to observe hESC-like colonies, in some cases up to 25 days post-transduction.
RELATED PRODUCTS & SERVICES
For research use only. Not for any other purpose.